HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by West, W. H. L. Articles by Toms, G. L. Search for Related Content PubMed PubMed Citation Articles by West, W. H. L. Articles by Toms, G. L. Agricola Articles by West, W. H. L. Articles by Toms, G. L.

Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus

C. Bourgeois

Division of Virology, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, U.K.

The neutralizing activity and fusion-inhibition activity per unit weight of immunoglobulin were determined for each of a panel of 20 monoclonal antibodies (MAbs) to the fusion (F) protein of respiratory syncytial (RS) virus. Neutralization did not correlate with fusion-inhibiting activity, suggesting that the F protein plays at least two independent, antibody-sensitive roles in viral infection. Antibodies with the highest biological activity against A2, a subgroup A strain of RS virus, neutralized a subgroup B strain (8/60) poorly, suggesting a degree of antigenic variation that may be important in human infection.

All but one fusion-inhibiting MAb bound to protein blots and binding was mapped to two areas on overlapping F protein fragments. One MAb with relatively poor fusion-inhibiting activity bound only to fragments C-terminal of amino acid 384, the remainder bound only to fragments containing residues 253 to 289. MAbs directed to the latter site were heterogeneous in neutralizing activity, subgroup specificity and fusion-inhibiting activity. These variations between MAbs could not be accounted for by differences in their binding avidities. We suggest that this binding site is not the complete antibody epitope which probably includes conformation-dependent elements.

Present address: Laboratoire de Virologie, Faculte de Medecine, Dijon Cedex, France.

Received 25 February 1994; accepted 29 April 1994.

This article has been cited by other articles:

				C. Mekseepralard, G. L. Toms, and E. G. Routledge Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1267 - 1273. [Abstract] [Full Text] [PDF]

				F. Kostolanský, E. Varecková, T. Betáková, V. Mucha, G. Russ, and S. A. Wharton The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin J. Gen. Virol., July 1, 2000; 81(7): 1727 - 1735. [Abstract] [Full Text]

				C. Bourgeois, J. B. Bour, L. S. Aho, and P. Pothier Prophylactic Administration of a Complementarity-Determining Region Derived from a Neutralizing Monoclonal Antibody Is Effective against Respiratory Syncytial Virus Infection in BALB/c Mice J. Virol., January 1, 1998; 72(1): 807 - 810. [Abstract] [Full Text] [PDF]